The global Afoxolaner Chewable Tablets market growth is projected to reach US$ 1415 million in 2025 to US$ 2707 million in 2031; it is expected to grow at a CAGR of 11.4% from 2025 to 2031.

Global Afoxolaner Chewable Tablets Market Trends And Outlook 2025-31

The global Afoxolaner Chewable Tablets market size is predicted to grow from US$ 1415 million in 2025 to US$ 2707 million in 2031; it is expected to grow at a CAGR of 11.4% from 2025 to 2031. Meaning Afoxolaners chewable tablets United States market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Afoxolaner Chewable Tablets players cover Merial Toulouse, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the ?Afoxolaner Chewable Tablets Industry Forecast? looks at past sales and reviews total world Afoxolaner Chewable Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Afoxolaner Chewable Tablets sales for 2025 through 2031. With Afoxolaner Chewable Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afoxolaner Chewable Tablets industry. This Insight Report provides a comprehensive analysis of the global Afoxolaner Chewable Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afoxolaner Chewable Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Afoxolaner Chewable Tablets market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afoxolaner Chewable Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afoxolaner Chewable Tablets. This report presents a comprehensive overview, market shares, and growth opportunities of Afoxolaner Chewable Tablets market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Afoxolaner Chewable Tablets &nbsp;&nbsp;&nbsp; Afoxolaner and Milbemycin Oxime Chewable Tablets Segmentation by Application: &nbsp;&nbsp;&nbsp; Tick Infection in Dogs &nbsp;&nbsp;&nbsp; Gastrointestinal Nematode Infection in Dogs &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merial Toulouse &nbsp;&nbsp;&nbsp; Boehringer Ingelheim Key Questions Addressed in this Report What is the 10-year outlook for the global Afoxolaner Chewable Tablets market? What factors are driving Afoxolaner Chewable Tablets market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Afoxolaner Chewable Tablets market opportunities vary by end market size? How does Afoxolaner Chewable Tablets break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Afoxolaner Chewable Tablets Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Afoxolaner Chewable Tablets by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Afoxolaner Chewable Tablets by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Afoxolaner Chewable Tablets Segment by Type &nbsp;2.2.1 Afoxolaner Chewable Tablets &nbsp;2.2.2 Afoxolaner and Milbemycin Oxime Chewable Tablets &nbsp;2.3 Afoxolaner Chewable Tablets Sales by Type &nbsp;2.3.1 Global Afoxolaner Chewable Tablets Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Afoxolaner Chewable Tablets Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Afoxolaner Chewable Tablets Sale Price by Type (2020-2025) &nbsp;2.4 Afoxolaner Chewable Tablets Segment by Application &nbsp;2.4.1 Tick Infection in Dogs &nbsp;2.4.2 Gastrointestinal Nematode Infection in Dogs &nbsp;2.4.3 Other &nbsp;2.5 Afoxolaner Chewable Tablets Sales by Application &nbsp;2.5.1 Global Afoxolaner Chewable Tablets Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Afoxolaner Chewable Tablets Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Afoxolaner Chewable Tablets Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Afoxolaner Chewable Tablets Breakdown Data by Company &nbsp;3.1.1 Global Afoxolaner Chewable Tablets Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Afoxolaner Chewable Tablets Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Afoxolaner Chewable Tablets Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Afoxolaner Chewable Tablets Revenue by Company (2020-2025) &nbsp;3.2.2 Global Afoxolaner Chewable Tablets Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Afoxolaner Chewable Tablets Sale Price by Company &nbsp;3.4 Key Manufacturers Afoxolaner Chewable Tablets Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Afoxolaner Chewable Tablets Product Location Distribution &nbsp;3.4.2 Players Afoxolaner Chewable Tablets Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Afoxolaner Chewable Tablets by Geographic Region &nbsp;4.1 World Historic Afoxolaner Chewable Tablets Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Afoxolaner Chewable Tablets Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Afoxolaner Chewable Tablets Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Afoxolaner Chewable Tablets Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Afoxolaner Chewable Tablets Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Afoxolaner Chewable Tablets Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Afoxolaner Chewable Tablets Sales Growth &nbsp;4.4 APAC Afoxolaner Chewable Tablets Sales Growth &nbsp;4.5 Europe Afoxolaner Chewable Tablets Sales Growth &nbsp;4.6 Middle East & Africa Afoxolaner Chewable Tablets Sales Growth 5 Americas &nbsp;5.1 Americas Afoxolaner Chewable Tablets Sales by Country &nbsp;5.1.1 Americas Afoxolaner Chewable Tablets Sales by Country (2020-2025) &nbsp;5.1.2 Americas Afoxolaner Chewable Tablets Revenue by Country (2020-2025) &nbsp;5.2 Americas Afoxolaner Chewable Tablets Sales by Type (2020-2025) &nbsp;5.3 Americas Afoxolaner Chewable Tablets Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Afoxolaner Chewable Tablets Sales by Region &nbsp;6.1.1 APAC Afoxolaner Chewable Tablets Sales by Region (2020-2025) &nbsp;6.1.2 APAC Afoxolaner Chewable Tablets Revenue by Region (2020-2025) &nbsp;6.2 APAC Afoxolaner Chewable Tablets Sales by Type (2020-2025) &nbsp;6.3 APAC Afoxolaner Chewable Tablets Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Afoxolaner Chewable Tablets by Country &nbsp;7.1.1 Europe Afoxolaner Chewable Tablets Sales by Country (2020-2025) &nbsp;7.1.2 Europe Afoxolaner Chewable Tablets Revenue by Country (2020-2025) &nbsp;7.2 Europe Afoxolaner Chewable Tablets Sales by Type (2020-2025) &nbsp;7.3 Europe Afoxolaner Chewable Tablets Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Afoxolaner Chewable Tablets by Country &nbsp;8.1.1 Middle East & Africa Afoxolaner Chewable Tablets Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Afoxolaner Chewable Tablets Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Afoxolaner Chewable Tablets Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Afoxolaner Chewable Tablets Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Afoxolaner Chewable Tablets &nbsp;10.3 Manufacturing Process Analysis of Afoxolaner Chewable Tablets &nbsp;10.4 Industry Chain Structure of Afoxolaner Chewable Tablets 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Afoxolaner Chewable Tablets Distributors &nbsp;11.3 Afoxolaner Chewable Tablets Customer 12 World Forecast Review for Afoxolaner Chewable Tablets by Geographic Region &nbsp;12.1 Global Afoxolaner Chewable Tablets Market Size Forecast by Region &nbsp;12.1.1 Global Afoxolaner Chewable Tablets Forecast by Region (2026-2031) &nbsp;12.1.2 Global Afoxolaner Chewable Tablets Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Afoxolaner Chewable Tablets Forecast by Type (2026-2031) &nbsp;12.7 Global Afoxolaner Chewable Tablets Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merial Toulouse &nbsp;13.1.1 Merial Toulouse Company Information &nbsp;13.1.2 Merial Toulouse Afoxolaner Chewable Tablets Product Portfolios and Specifications &nbsp;13.1.3 Merial Toulouse Afoxolaner Chewable Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merial Toulouse Main Business Overview &nbsp;13.1.5 Merial Toulouse Latest Developments &nbsp;13.2 Boehringer Ingelheim &nbsp;13.2.1 Boehringer Ingelheim Company Information &nbsp;13.2.2 Boehringer Ingelheim Afoxolaner Chewable Tablets Product Portfolios and Specifications &nbsp;13.2.3 Boehringer Ingelheim Afoxolaner Chewable Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Boehringer Ingelheim Main Business Overview &nbsp;13.2.5 Boehringer Ingelheim Latest Developments 14 Research Findings and Conclusion

Report	Global Afoxolaner Chewable Tablets Market Growth 2025-2031
Selected License	Multi ID: LPI10629

Buyer Information

Order Summary